医学
聚ADP核糖聚合酶
癌症研究
转移
卵巢癌
上皮性卵巢癌
同源重组
PARP抑制剂
体内
癌症
聚合酶
基因
内科学
生物
遗传学
作者
Z. Ping Lin,Yong Zhu,Ying‐Chun Lo,Pamela H. Huang,Elena Ratner
标识
DOI:10.1016/j.ygyno.2019.04.614
摘要
Objective: BRCA mutations lead to defective homologous recombination (HR) repair that underpins the development and progression of epithelial ovarian cancer (EOC) and renders hypersensitivity to poly(ADP-ribose) polymerase (PARP) inhibitor and platinum therapy. The objective of this study was to investigate the mechanism by which defective HR repair perpetuated invasion and metastasis of EOC in vitro and in vivo, as well as its therapeutic implications.
科研通智能强力驱动
Strongly Powered by AbleSci AI